Pergolide versus bromocriptine
Login, I.S.
Neurology 34(2): 258
1984
ISSN/ISBN: 0028-3878 PMID: 6538025 Document Number: 229602
Document emailed within 1 workday
Related Documents
Buvat, J.; Buvat-Herbaut, M. 1982: Prolactin, bromocriptine and gonadal function in women: recent advances. II. Treatment of female hyperprolactinemia and other indications for the use of bromocriptine Journal de Gynecologie Obstetrique et Biologie de la Reproduction 11(4): 509-521Loison, S.; Turpin, G.; Scherrer, H.; de Gennes, J.L. 1987: Treatment of hyperprolactinemias by pergolide mesylate Presse Medicale 16(28): 1377
Neshige, R. 2005: Optimum dosage of pergolide in patients with Parkinson's disease Rinsho Shinkeigaku 45(4): 328-330
Bilici, A.; Karadag, B.; Doventas, A.; Erdincler, D.S.; Cetinkaya, S.; Ogut, G.; Tezcan, V.; Beger, T. 2004: Retroperitoneal fibrosis caused by pergolide in a patient with Parkinson's disease Netherlands Journal of Medicine 62(10): 389-392
Fuller, R.W.; Snoddy, H.D. 1982: Serum corticosterone elevation by pergolide in rats: prevention of tolerance development by spiperone Journal of Pharmacy and Pharmacology 34(9): 607-608
Asanuma, M.; Ogawa, N.; Nishibayashi, S.; Kawai, M.; Kondo, Y.; Iwata, E. 1995: Protective effects of pergolide on dopamine levels in the 6-hydroxydopamine-lesioned mouse brain Archives Internationales de Pharmacodynamie et de Therapie 329(2): 221-230
Olanow, C.W.; Alberts, M.J. 1987: Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease Advances in Neurology 45: 555-560
Cavero, I.; Lorrain, J.; Di Paola, E.D.; Lhoste, F.; Payen, B.; Dennis, T.; Scatton, B. 1985: Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs Journal of Pharmacology and Experimental Therapeutics 235(3): 798-809
Fuller, R.W.; Clemens, J.A.; Hynes, M.D. 1982: Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia Journal of Clinical Psychopharmacology 2(6): 371-375
1978: Bromocriptine and parkinsonism New Zealand Medical Journal 87(614): 437-438
Takeda, S.; Inoue, K. 1997: Bromocriptine provocative test Nihon Rinsho. Japanese Journal of Clinical Medicine 55(Suppl 2): 234-237
Gunston, G.D. 1996: Bromocriptine for inhibition of lactation South African Medical Journal 86(7): 845
Peters, F. 1984: Use of bromocriptine in diseases of the breast Akusherstvo i Ginekologiia 5: 20-22
Borenstein, P.; Soret, C.; Graille, D. 1981: The effect of bromocriptine on the course of dementia La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 57(15-16): 801-809
Tuneu Valls, L.; Cao Vispo, C.; Sanmartín Suñer, M.; Cols Jiménez, M. 1996: Use of bromocriptine in suppression of lactation Medicina Clinica 106(15): 598
Dolecek, R.; Kubis, M.; Sajnar, J.; Závada, M. 1982: Bromocriptine and glucose tolerance in acromegalics Pharmatherapeutica 3(2): 100-106
Teychenne, P.F.; Leigh, P.N.; Reid, J.L.; Calne, D.B.; Greenacre, J.K.; Petrie, A.; Bamji, A.N. 1975: Idiopathic parkinsonism treated with bromocriptine Lancet 2(7933): 473-476
Bacz, A. 1982: Bromocriptine - new drug in gynecology and obstetrics Ginekologia Polska 53(5-6): 291-296
Jaedig, S. 1982: Medical treatment of acromegaly with bromocriptine Ugeskrift for Laeger 144(47): 3514-3515
Vermersch, P.; Foissac-Gegoux, P.; Caron, J.; Petit, H. 1989: Retroperitoneal fibrosis after treatment with bromocriptine Presse Medicale 18(16): 841